Clinical outcome of COVID-19 in patients with adult congenital heart disease.

Schwerzmann, Markus; Ruperti-Repilado, Francisco Javier; Baumgartner, Helmut; Bouma, Berto; Bouchardy, Judith; Budts, Werner; Campens, Laurence; Chessa, Massimo; Del Cerro Marin, Maria Jesús; Gabriel, Harald; Gallego, Pastora; Garcia-Orta, Rocio; Gonzalez, Ana Elvira; Jensen, Annette Schophuus; Ladouceur, Magalie; Miranda-Barrio, Berta; Morissens, Marielle; Pasquet, Agnes; Rueda, Joaquín; van den Bosch, Annemien E; ... (2021). Clinical outcome of COVID-19 in patients with adult congenital heart disease. Heart (British Cardiac Society), 107(15), pp. 1226-1232. BMJ Publishing Group 10.1136/heartjnl-2020-318467

[img]
Preview
Text
1226.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (576kB) | Preview

AIMS

Patients with adult congenital heart disease (ACHD) are a potentially vulnerable patient cohort in case of COVID-19. Some cardiac defects may be associated with a poor COVID-19 outcome. Risk estimation in ACHD is currently based on expert opinion. The aim of this study was to collect clinical outcome data and to identify risk factors for a complicated course of COVID-19 in patients with ACHD.

METHODS

Twenty-five ACHD centres in nine European countries participated in the study. Consecutive patients with ACHD diagnosed with COVID-19 presenting to one of the participating centres between 27 March and 6 June 2020 were included. A complicated disease course was defined as hospitalisation for COVID-19 requiring non-invasive or invasive ventilation and/or inotropic support, or a fatal outcome.

RESULTS

Of 105 patients with a mean age of 38±13 years (58% women), 13 had a complicated disease course, of whom 5 died. In univariable analysis, age (OR 1.3, 95% CI 1.1 to 1.7, per 5 years), ≥2 comorbidities (OR 7.1, 95% CI 2.1 to 24.5), body mass index of >25 kg/m2 (OR 7.2, 95% CI 1.9 to 28.3) and cyanotic heart disease (OR 13.2, 95% CI 2.5 to 68.4) were associated with a complicated disease course. In a multivariable logistic regression model, cyanotic heart disease was the most important predictor (OR 60.0, 95% CI 7.6 to 474.0).

CONCLUSIONS

Among patients with ACHD, general risk factors (age, obesity and multiple comorbidities) are associated with an increased risk of complicated COVID-19 course. Congenital cardiac defects at particularly high risk were cyanotic lesions, including unrepaired cyanotic defects or Eisenmenger syndrome.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Schwerzmann, Markus and Ruperti Repilado, Francisco Javier

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1468-201X

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Markus Schwerzmann

Date Deposited:

08 Feb 2022 16:37

Last Modified:

08 Feb 2022 16:37

Publisher DOI:

10.1136/heartjnl-2020-318467

PubMed ID:

33685931

Uncontrolled Keywords:

congenital heart defects

BORIS DOI:

10.48350/164741

URI:

https://boris.unibe.ch/id/eprint/164741

Actions (login required)

Edit item Edit item
Provide Feedback